Hydroxychloroquine for COVID-19

Off-label COVID-19 treatment approach involving hydroxychloroquine, often discussed in early COVID-19 treatment protocols. Hydroxychloroquine was widely discussed early in the COVID-19 pandemic as a possible outpatient or early-treatment agent, including in medical-freedom and early-treatment advocacy circles. Peter A. Mc Cullough has been associated with the broader early-treatment movement that included hydroxychloroquine and other repurposed medications.